Related Experiment Video
Updated: Jun 11, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Screening for cardiovascular disease in patients with advanced chronic kidney disease
1Department of Cardiology, Ealing Hospital NHS Trust, London, UK. heddington@doctors.org.uk
Insights
Cardiovascular disease is a major risk for advanced chronic kidney disease (CKD) patients. This review assesses cardiac diagnostic tools, finding echocardiography and stress tests useful but no single test predicts sudden cardiac death.
Area of Science:
- Nephrology
- Cardiology
- Diagnostic Imaging
Background:
- Cardiovascular disease (CVD) is the primary cause of death and illness in advanced chronic kidney disease (CKD) and post-renal transplant patients.
- Identifying patients at high risk for cardiac events is challenging, impacting long-term outcomes for dialysis patients and renal transplant candidate selection.
Purpose of the Study:
- To evaluate the diagnostic accuracy and prognostic value of various cardiac tests in patients with advanced CKD.
- To guide the selection of appropriate cardiac investigations for this high-risk population.
Main Methods:
- Review of current literature on diagnostic cardiac imaging modalities.
- Analysis of the strengths and limitations of echocardiography, stress echocardiography, myocardial perfusion imaging, and coronary angiography.
Main Results:
- Echocardiography effectively detects cardiomyopathy and provides prognostic information.
- Stress echocardiography, myocardial perfusion imaging, and coronary angiography are optimal for assessing coronary artery disease and predict patient outcomes.
- Currently, no single diagnostic test reliably predicts sudden cardiac death in advanced CKD patients.
Conclusions:
- Multiple cardiac tests are valuable for risk stratification in advanced CKD patients, but no single gold standard exists.
- The choice of cardiac testing should consider patient factors, local expertise, and test availability.
- Further research is needed to identify optimal methods for predicting sudden cardiac death in this population.
Abstract:
Cardiovascular disease remains the major cause of mortality and morbidity in patients with advanced chronic kidney disease (CKD) and after renal transplantation. The mechanisms for cardiotoxicity are multiple. Identifying high-risk patients remains a challenge. Given, the poor long-term outcome of dialysis patients who do not receive renal transplantation and the lower supply of donor kidneys relative to demand, optimal selection of renal transplantation candidates is crucial. This requires a clear understanding of the validity of cardiac tests in this patient group. This paper explores the strengths and weaknesses of currently available diagnostic tools in patients with advanced CKD. Echocardiography is very useful for the detection of cardiomyopathy and prognosis. Stress echocardiography, myocardial perfusion imaging and coronary angiography are the best tools for the assessment of coronary artery disease. All predict outcome. No single gold standard investigation exists. At present, there is not an optimal technique for predicting sudden cardiac death in this patient group. Ultimately, the choice of cardiac test will always be determined by patient preference, local expertise and availability.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
